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ABSTRACT 
 The main objective of this study was to retrospectively report our institutional 
outcomes with the long-term management of neurogenic bladder in spinal cord injury 
patients. Specifically to: (A) report the association of recurrent urinary tract infection 
(UTI) with the long-term use of clean intermittent catheterization (CIC) in our population 
of spinal cord injury (SCI) patients. (B) Secondly, to evaluate the use of retroperitoneal 
ultrasound for long-term renal tract surveillance in injured patients. (C) And thirdly, to 
describe our experience with the use of the lowsley retractor method for suprapubic 
cystostmy in patients with neurogenic bladder. 
 Subjects were selected from patients followed by one physician at the Yale 
Urology Medical Group and their medical records were retrospectively reviewed. To 
address objectives (A) and (B), patients were identified after a search of the Financial 
Department’s database with diagnosis codes for “neurgenic bladder” and “Spinal cord 
injury.” Patients seen between the years 2000 to 2010 were included in the study. For 
objective (C), patients were identified with diagnosis code for “cystostomy” and patients 
seen between 1995 and 2010 were included in the study. 
 For objective (A), 51 male and 10 female subjects were managed with CIC. 41 
(67%) subjects were placed on medical prophylaxis (PRx) for symptomatic recurrent 
UTI. 28 (72%) subjects were started on PRx within 2 years after initiation of CIC. 48 SCI 
patients were included in objective (B). Mean follow-up was 6.8 years. By final follow-
up 7 (15%) subjects had moderate/minimal hydronephrosis. 4 (8%) cases were new 
compared to initial assessment. No severe cases of hydronephrosis were noted. For 
objective (C), 49 primary catheter placements were performed on 44 patients. Operation-
time documented in 19 (39%) cases was 20.2 min (5.5) (range: 11-31 min). Blood loss 
was minimal and there were no intra-operative complications or cases of incorrect 
catheter placements. 
The improved life expectancy of SCI patients in recent decades makes long-term 
complications of neurogenic bladder management more pertinent. Although CIC is the 
current standard of care following SCI, recurrent UTI remains a major complication in 
patients using this technique. Due to a lack of standard guidelines for long-term renal 
tract monitoring in injured patients, there is wide variation in surveillance strategies. Our 
results suggest that annual retroperitoneal ultrasound is effective for renal tract 
monitoring rather than subjecting patients to annual urodynamic testing. Furthermore, the 
improved anticholinergic therapy makes suprapubic catheters an acceptable alternative to 
intermittent catheterization. Our findings support the use of the lowsley retractor method 
of suprapubic catheter placement as a safe and effective method for isolated suprapubic 
cystostomy in neurogenic bladder patients.
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INTRODUCTION 
Renal disease resulting from neurogenic voiding dysfunction has historically been 
the leading cause of death in individuals with spinal cord injury (SCI). The decision to 
create special spinal injury units within selected hospitals during the Second World War 
prompted the modern era of treatment of spinal cord injured persons [1]. These regional 
specialized treatment units played an important role in studying and better understanding 
the needs of injured patients [2]. Subsequent advances in urologic management are 
credited for the improved survival in this patient population [3]
 
and life-long urologic 
follow-up is critical to maintain quality of life and minimize urinary tract associated 
morbidity. The improved life expectancy in SCI patients attained by these advances in 
urologic care makes long-term complications of the urinary tract more pertinent, 
therefore mandating continued research related to urinary tract dysfunction. 
 
The Neurogenic Bladder in Spinal Cord Injury 
Neurogenic bladder (NGB) is broadly defined as the abnormal function of the 
urinary bladder secondary to any neurologic condition of the central nervous system or 
the peripheral nerves involved in the control of micturition [4]. Such neurologic 
conditions include spinal cord injury (SCI), neural tube defects, multiple sclerosis (MS), 
brain tumors as well as other diseases of peripheral nerves. In order to minimize the 
variability in subjects, this work specifically focuses on cases of neurogenic bladder 
caused by traumatic spinal cord injury. 
It is estimated that about 12,000 new cases of spinal cord injury occur in the 
United States each year, with an estimated prevalence of 262,000 persons in the year 
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2009 [5]. Alteration in the function of the lower urinary tract is one of the most 
problematic consequences of spinal cord lesions resulting in urologic complications 
following SCI. Although the mortality related to such complications has been 
significantly reduced in recent decades [6], urinary tract problems remain a prominent 
cause of morbidity [7]. These problems account for the majority of hospital readmissions 
following SCI [8] and necessitate life-long urologic follow up as a central component in 
the routine care of injured patients. 
The effect of spinal cord injury on the urethral sphincter and on the function of 
the detrusor muscle is the cause of neurogenic bladder dysfunction [9]. The degree of 
damage to the voiding cycle depends on the location, completeness as well as the 
vascular extension of the injury. A model of supraspinal bladder control is suggested by 
brain imaging studies. According to this model afferent signals from the lower urinary 
tract are received in the periaqueductal gray and relayed via the thalamus to the insula 
(which makes sensations accessible to conscious awareness). The cortex (via the anterior 
cingulate gyrus) monitors and controls micturition reflexes and also makes voluntary 
voiding decisions (via the prefrontal cortex) [10]. 
The normal micturition reflex is thought to be mediated by an area of the pons 
known as the pontine micturition center (PMC) or Barrington nucleus. This region 
coordinates the activity of the detrusor and urethral sphincter muscles [11, 12, 13]. The 
tip of spinal cord is located in the L1/L2 level of the vertebrae, however the detrusor 
muscle of the bladder and the internal urethral sphincter are innervated by 
parasympathetic sacral nerve roots (S2-S4) via the pelvic splanchnic nerve, in addition to 
some sympathetic innervation by T10-L2 nerve roots via the hypogastric nerve.  On the 
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other hand, the external urethral sphincter is innervated by somatic sacral nerve roots (S2-
S4) via the pudendal nerve. Injuries to the lumbar spine can destroy the conus of the cord 
or the cauda equina resulting in the loss of sacral reflexes.  The loss of sacral reflex 
activity will produce detrusor areflexia (DA), and flaccid paraplegia. Since injuries to the 
cervical and thoracic regions of the cord occur above the conus they typically cause 
detrusor hyperactivity (DH) and detrusor external sphincter dyssynergia (DESD), which 
describes the contraction of the bladder against a closed external sphincter. Quadriplegia 
may be observed if a complete cervical injury occurs. 
The urologic function following SCI is generally categorized into three phases: 
(1) spinal shock, (2) recovery, and (3) stable phases [14].  Immediately following the 
initial injury, the swelling of the spinal cord fills the spinal canal and prevents 
oxygenation and blood flow to the spinal cord tissue. This precipitates spinal shock, 
which involves a temporary loss of function in the undamaged areas of the spinal cord 
causing the inhibition of all reflexes and function distal to the level of injury and resulting 
in a flaccid detrusor [15]. The recovery phase refers to the return of reflex activity and 
marks the end of spinal shock. Following the recovery phase, a fairly stable urodynamic 
picture is observed, this marks the stable phase and it represents the period when there are 
no further signs of neurologic recovery. 
 
Bladder Management with Catheterization 
Various modalities are employed in the management of neurogenic bladders after 
the stable phase is reached. Common catheterization methods include the use of clean 
intermittent catheters, indwelling urethral catheters, or indwelling suprapubic catheters. 
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The technique of clean intermittent catheterization was introduced in 1972 [16] and 
involves the passage of a clean (non-sterile) straight catheter through the urethra to empty 
the bladder. Catheterization is typically done about 4 to 6 times daily.  Indwelling 
urethral catheterization involves leaving a trans-urethral foley catheter in the bladder, 
secured by a balloon, with a drainage bag attached usually to the thigh. The catheter is 
typically replaced every 3 to 4 weeks. An indwelling suprapubic catheter involves the 
creation of a surgical vesicostomy through the lower abdominal wall to allow a catheter 
to be placed into the bladder suprapubically. The tube is also replaced every 3 to 4 weeks. 
Individuals managed with long-term urinary catheters are at risk for many serious 
complications including: urethral complications such as the formation of strictures and 
false passages, chronic obstruction due to urinary calculi and periurethral infections 
including epididymitis and prostatitis. Other associated complications include life 
threatening complications such as pyelonephritis and bladder cancer. 
The optimal catheterization method for managing the neurogenic bladder remains 
controversial because no randomized studies have been done to determine which method 
of catheterization is superior in the long-term management of spinal cord injured patients. 
Many studies addressing this topic have reached different conclusions. In a comparative 
study of 80 patients in Karachi Pakistan, Turi and colleagues found intermittent 
catheterization to be superior to indwelling catheterization with respect to complications 
and infections rates [17]. And a retrospective study of 316 posttraumatic spinal cord 
injured patients with a mean follow-up of 18 years concluded that CIC is the safest 
method of bladder management with respect to urological complications [18]. On the 
other hand, a comparative study in Helsinki, Finland, by Dahberg and associates found a 
   - 5 - 
  
lower incidence of UTI’s in patients managed with suprapubic tapping compared to those 
with intermittent catheterization [19]. Other studies have not found significant differences 
in the incidence of urological complications between spinal cord injury patients managed 
with or without a bladder catheter [20]. 
 The most recent Cochrane review addressing this issue included about 400 
studies comparing these methods and found no evidence from randomized or quasi-
randomized controlled trials to draw any conclusions about the use of catheters [21]. The 
panel of experts at the Infectious Diseases Society of America (IDSA) similarly 
determined, in 2009, that there was insufficient evidence to recommend whether: 
suprapubic catheterization was superior to indwelling urethral catheterization or whether 
intermittent catheterization is superior to supra-pubic catheterization for reduction of 
catheter associated urinary tract infection (UTI) [22]. 
Regardless of the lack of randomized controlled trial to determine the superior 
catheterization method, clean intermittent catheterization is popularly believed to be 
associated with fewer complications compared with indwelling catheters and it is widely 
accepted as the preferred method of bladder management. Hill and Davies, in 1988, 
proposed the use of self intermittent catheterization as the preferred bladder management 
method in all spinally injured patients with good hand function [23]. This technique was 
recommended by the international consortium on incontinence, in 2010, as the first 
choice for individuals that are unable to empty their bladder adequately and safely [24]. 
 
A Second Line in Bladder Management 
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Indwelling suprapubic catheterization is currently used as a second-line for 
neurogenic bladder management in appropriate patients usually after failed CIC or severe 
urethral damage [25].  A recent review on the role of SPC in treatment of NGB suggests 
that although early reports of long-term renal and bladder complications discouraged its 
use for long-term NGB management, current improved pharmacotherapy with anti-
cholinergics and better bladder maintenance strategies may have improved its efficacy 
[26]. Sheriff et al. reported that 82% of patients with long-term suprapubic catheters 
indicated that it positively improved their quality of life [25]. The placement of 
suprapubic catheters in NGB patients is often done as an isolated procedure and is 
thought to have a low associated risk. However, the risk of intra-operative and post-
operative complications has been demonstrated to be higher in patients with NGB 
compared to those with other lower urinary tract dysfunction.  Ahluwalia et al. reported a 
34% overall complication rate in NGB patients compared to 18% in patients with other 
forms of bladder outflow obstruction (P = 0.057) and recommended that such high-risk 
cases be performed in a controlled environment with senior surgeon and anesthesia 
present [27]. 
Suprapubic catheter placement can be done with an open technique or by using 
one of the various percutaneous or other minimally invasive methods [28]. Each 
approach has its limitations; the open technique is considered the definitive gold-standard 
but it requires a larger incision, with potentially longer operative time, and more blood 
loss [29]. The risk of complication using blind percutaneous technique is low but such 
complication can be fatal. Such risks include through and through puncture of the bladder 
and potential injury to the bowel [30].  Ahluwalia et al. described a 2.5% risk of bowel 
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injury and 1.8% mortality rate in a retrospective report of their experience with 219 cases 
of SPC under cystoscopic guidance.   The imaging guided technique was introduced to 
reduce the risks associated with the percutaneous approach [31]. Cronin and colleagues 
recently reported their experience with the imaging-guided approach in a review of SPC 
performed on 549 patients by skilled interventional radiologists using either the trocar or 
seldinger technique [32]. Their procedures involved transurethral distention of the 
bladder with contrast material and imaging-guided cystostomy using a combination of 
ultrasound and fluoroscopy. The use of ultrasonography however is limited by the skill of 
the practitioner and a disadvantage of fluoroscopy is the risks associated with exposing 
patients to ionizing radiation. 
 
Long-Term Complications 
SCI patients suffer from various degrees of detrusor dysfunction, including 
hyperreflexia, areflexia, detrusor sphincter dyssynergia, poor compliance and chronic 
urinary tract infection. Urodynamic testing is thought to be the most important predictor 
of the urologic outcome [33].  This test measures the pressure in the bladder and the 
electrical activity of the urethral sphincter to determine the effects of the neurological 
injury. It is used to define the type of neurogenic dysfunction and for planning the 
bladder management strategy. The findings of urodynamic testing after the patient is 




Amongst the most common urologic manifestations of neurogenic voiding 
dysfunction is the problem of recurring UTIs. The vast majority of UTIs are caused by 
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organisms that are commonly present in the bowel and on the perineal skin, including 
gram-negative bacilli and enterococci [7]. Factors contributing to risk of UTI in persons 
with SCI include incomplete emptying of the bladder, low bladder wall compliance and 
insertion of urinary catheters. 
Due to the widespread use of urinary catheterization, bacteriuria associated with 
the use of catheters is the most common healthcare-assocaited infection worldwide [22]. 
Long-term indwelling urinary catheterization inevitably results in lower urinary tract 
colonization. Significant levels of bacteria can be seen in the urine of patients managed 
by an indwelling catheter within 72 hours of insertion, and levels of bacteria increase 5% 
to 8% per day [34]. In comparison, while the likelihood of chronic bacteriuria is also 
increased by CIC, it is believed that this risk is offset by the benefit of not having the 
continued presence of a foreign object in the lower urinary tract.  
 There is an important distinction between asymptomatic bacteriuria and 
symptomatic urinary tract infections. Most neurogenic bladder patients will have 
bacteriuria yet they remain free from symptoms associated with a UTI and can be 
described as having “asymptomatic bacteriuria.” An immune response triggered by 
bacterial invasion of the bladder wall causes the symptoms of “clinical UTI [35].” While 
an increased risk of symptomatic UTI is associated with asymptomatic bacteriuria, the 
use of antibiotics is not indicated unless UTI symptoms develop [15].  
 The routine use of antimicrobial prophylaxis remains controversial due to many 
conflicting results from studies looking at its efficacy in preventing infections. A meta-
analysis of 15 controlled trials did not find a significant reduction in symptomatic 
infections when prophylactic antimicrobials were administered, rather, the use of 
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antimicrobial prophylaxis was found to double the amount of antimicrobial-resistant 
organisms [36]. Routine cultures in healthy asymptomatic patients are similarly 
discouraged since the practice causes an unnecessary treatment of bacteriuria [37]. 
Beyond urinary tract infections, renal deterioration is a fatal long-term 
consequence of poor bladder management. The goal of urologic management in SCI is to 
prevent upper tract deterioration and maintain continence. Renal deterioration leading to 
renal failure is principally caused by vesicoureteral reflux, chronic pyelonephritis, renal 
stone formation and hydronephrosis [38]. Normal bladder function requires urine storage 
at low intravesical pressure without leakage. Therefore, efforts to preserve adequate 
urinary tract function must maintain adequate detrusor pressures. 
 McGuire and colleagues in 1983 determined that high detrusor leak point 
pressure was related to upper tract deterioration [39]. Outlet obstruction associated with 
detrusor leak point pressure greater than 40 cm is now considered the major risk factor 
for upper tract deterioration [40, 41].
 
It is explained that an elevated urethral resistance 
causes deterioration in compliance that results in an increased detrusor pressure (Pdet). 
The increased Pdet is transmitted to the ureter consequently increasing the ureteral work 
until it reaches a limit at about 40 cm of water. At this point the delivery of urine from the 
ureter to the bladder ceases. It is therefore believed that the effects on the ureter seen by 
imaging are late rather than immediate changes of lower tract dysfunction [42].
 
 
Urinary Tract Surveillance 
 There are no standard guidelines established to routinely monitor the urinary tract 
in spinal cord injury patients due to the low availability of data relating to the value of 
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various routine surveillance methods. This has resulted in wide variability in renal tract 
surveillance strategies in practices around the world [43, 44]. Most urological centers 
prefer annual monitoring of upper and lower urinary tract function with either an upper 
tract study or a compliance test [45]. The European Association of Urology (EAU) 
recommends video-urodynamic investigation every 2 years for patients with normal 
bladder compliance who do not have detrusor overactivity. And recommend annual 
video-urodynamics for patients with detrusor overactivity and/or low bladder compliance 
[46]. Although well tolerated by patients [47], conventional urodynamic testing is 
sometimes avoided because it is expensive and carries a risk of urinary tract infection 
[48]. Nosseir and colleagues retrospectively investigated the long-term results of 80 SCI 
patients managed at their institution with a strictly urodynamic-based treatment regime 
and determined that physiologic changes in bladder function can occur in the absence of 
changes in overall symptoms thus they recommended annual urodynamic testing in 
patients with detrusor overactivity [49]. It is our position that renal tract changes can be 




Statement of purpose 
The primary objective of this investigation was to report outcomes related to the urologic 
management of our spinal cord injury patients with neurogenic bladder. 
Specifically: 
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a) To study the association of recurrent symptomatic urinary tract infections (UTI) 
with the long-term use of clean intermittent catheterization (CIC) for the 
management of neurogenic bladder in spinal cord injury (SCI) patients.  
b) To report our experience with the lowsley retractor method for suprapubic 
cystostomy (SPC) in patients with neurogenic bladder (NGB). 
c) To evaluate the efficacy of annual ultrasonography rather than regular 
urodynamic testing for upper tract surveillance in spinal cord injury (SCI) 
patients managed with long-term intermittent catheterization. 
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METHODS 
This study was approved by the institutional review board at Yale University School 
of Medicine. Subjects were selected from patients followed by one physician at the Yale 
Urology Medical Group and their medical records were retrospectively reviewed. All 
patient visits at the urology clinic were logged by the Patient Financial Services 
Department under corresponding diagnosis codes and clinic visits or phone calls were 
recorded in patient charts by the same physician after each encounter. 
a) In order to determine the association of UTI with the long-term use of CIC in our 


























Figure 1: Application of inclusion and exclusion criteria to determine association of 
UTIs with the long-term use of CIC. CIC = clean intermittent catheterization; SCI = 
spinal cord injury; UTI = urinary tract infection. 
930 patients seen by 1 physician between 2000 
and 2010 identified with diagnosis codes for: 
“neurogenic bladder” or “spinal cord Injury” 
720 Patients Excluded: 
 Neurogenic bladder  not 
caused by spinal cord injury 
210 Subjects with neurogenic bladder 
caused by spinal cord injury 
149 Patients Excluded: 
 Had less than 1 yr follow-up 
 Had urinary diversion 
 Not managed with CIC 
61 Subjects met inclusion criteria: 
 Neurogenic bladder caused by traumatic SCI 
 Managed with clean  intermittent catheterization 
 At least 1 yr of clinical follow-up 




Inclusion criteria: neurogenic bladder dysfunction; stable traumatic spinal cord injury 
at least one year after injury; bladder management with clean intermittent 
catheterization; minimum of one year follow-up by the same physician at the Yale 
Urology Clinic; patient seen between the years 2000 and 2010. 
 Exclusion criteria: other etiology for neurogenic bladder such as multiple sclerosis, 
parkinson’s disease, spina bifida or diabetes; other methods of bladder management 
including other catheterization methods, crede maneuver or patients with urinary 
diversion. 
A list of 930 potential subjects was generated by a search of the Financial 
Services records using diagnosis codes for "neurogenic bladder (596.54)" or "Spinal Cord 
Injury (952.9)." The search was limited to patients seen by the same physician at the Yale 
Urology Medical Group between the years 2000 and 2010.  Initial review of the clinical 
records eliminated 720 potential subjects who had neurogenic bladder from other 
etiology but did not have traumatic spinal cord injury.  Of the 210 spinal cord injury 
patients with neurogenic bladder, another 149 subjects were excluded either because they 
had neurogenic bladder managed by methods other than clean intermittent catheterization 
or had undergone urinary diversion. Only 61 traumatic spinal cord injury subjects with 
neurogenic bladder managed by intermittent catheterization and followed for at least one 
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Table 1. Patient characteristics 
Age (y) 43.4 16.3 
Sex (n)  
    Male 51 (84) 
    Female 10 (16) 
Injury level (n)  
    Cervical 24 (39) 
    Thoracic 24 (39) 
    Lumbar 12 (20) 
    Sacral 1 (2) 
Independence (n)  
    Paraplegic 35 (57) 
    Tetraplegic 18 (30) 
    Independent 8 (13) 
Duration of catheterization (y)  
   Before initiating PRx 2.7  3.3 
   Subjects not requiring PRx 7.2  3.8 
Duration of follow-up (y) 5.8  
Use of UTI PRx  
    Yes 41 (67) 
    No 20 (33) 
Data presented as mean  SD, unless noted 
otherwise; data in parentheses are percentages. PRx = 




For each research subject the following data points were recorded on Excel: 
Age 
Gender 
Level of spinal injury 
Amount of independence 
Mean years of follow-up at Yale 
Time elapsed since initial injury 
Frequency of catheterization  
Presence of incontinence 
Ultrasound findings 
Number of positive urine cultures 
Use of UTI prophylaxis  
Years after injury before using prophylaxis 
Type of UTI prophylaxis 
Number of symptomatic UTIs in last year 
Number of positive cultures in the year prior 
to starting prophylaxis 
Urodynamic findings 
Pharmacologic control of detrusor  
Surgical control of detrusor 
Number of symptomatic UTIs in last year 
 
All complications of bladder management were recorded based on the status of subjects 
at the time of their last urologic follow-up at Yale. 
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Outcome model 
Patients experiencing recurrent UTI were identified by their continued use of medical 
UTI-prophylaxis (PRx) at the time of last clinical follow-up.  Medical PRx in this case is 
defined as the use of either oral antibiotics or methenamine with ascorbic acid to decrease 
the frequency of UTIs. Subjects were started on PRx when they had experienced ≥ 3 
UTIs within a one (1) year period.  For subjects on UTI prophylaxis, the recurrent and 
symptomatic nature of their infections was verified by the number of positive cultures 
occurring within a year prior to starting prophylaxis. Subjects were not placed on PRx if 
they have not had at least three episodes of symptomatic UTI within a one year period. 
For each subject not placed on UTI prophylaxis, the number of symptomatic UTIs 
occurring in their final year of follow-up was recorded based on the number of times 
patients complained of UTI symptoms including cloudy/malodorous urine, increased 
incontinence, fever, chills and bladder spasms. Where available the number of positive 
cultures was also recorded. All cultures were done only after subjects complained of UTI 
symptoms and were considered positive when subjects had greater than 10
3
 colony 
forming units (cfu)/ml of ≥ 1 organism. 
 
b) Regarding the use of renal ultrasonography rather than regular urodynamic testing as 
a routine surveillance method in spinal cord injury patients, data was extracted from 
subjects identified in specific objective (a) who met further inclusion and exclusion 
criteria. 
Subjects included in this objective had received initial urodynamic testing to guide their 
pharmacologic and catheterization regimen. After a safe system had been established, 
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routine upper tract surveillance was done annually with ultrasonography of the renal 
tracts and bladder to monitor urinary tract stability. Urodynamic testing was repeated 
only when patients presented with new symptoms such as persistent urinary tract 
infections, increased leakage between catheterization, or with abnormal findings on 
ultrasonography. 
Data was gathered retrospectively from the medical records of 48 subjects (40 males 
and 8 females) who were included in the study. The inclusion criteria were: NB 
secondary to SCI; a minimum of one year follow-up at our institution; NB management 
with IC; and annual upper tract surveillance with retroperitoneal ultrasound. The primary 
endpoint was the presence or absence of abnormal ultrasound findings at the time of last 
renal tract surveillance. Specifically the finding of hydronephrosis/pelvicaliectasis, 
renal/ureteral calculi, and renal cortical scarring/thinning were noted. The duration of 
ultrasound follow-up, degree of disability, and baseline ultrasound and urodynamic 
findings were also noted. 
 
c) In order to report our institutional experience with the lowsley retractor method for 
suprapubic cystostomy, cases were evaluated as follows: 
Subjects were selected from patients undergoing suprapubic cystostomy by one surgeon 
at the Yale Urology Medical Group. A search of the billing department database was 
conducted with the procedure code for “cystostomy.” A list of 90 patients was generated 
and the medical records of these patients were retrospectively reviewed. Patients with 
neurogenic bladder, who underwent elective suprapubic cystostomy using the lowsley 
retractor method between the years 1995 and 2010 were included. Patients who 
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underwent cystostomy as part of other surgical procedures were excluded. The age and 
gender of subjects as well as the indication, anesthesia type, catheter size, blood loss, 
fluids administered, complications and duration of the procedure were recorded. 
 
 Statistical Analysis 
All analyses were done with SPSS statistics version 17.0. For comparisons of the mean 
age in males and females the student’s t-test was used. Data were represented as counts 
and percentages for categorical variables. Means and standard deviations were used for 
continuous variables.  P < 0.05 was considered statistically significant. 
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RESULTS 
a) Of 210 SCI patients with neurogenic bladder only 61 subjects, (51 males and 10 
females met the inclusion criteria for specific objective (a). 
 The mean age of the 61 subjects was 43.4 years (16.3) (range: 12-86 years).  The age 
were similar for male and female subjects; 43.5years (16.5) and 43.2 years (15.5) 
respectively. The mean duration of follow-up for all subjects was 5.8 years ( 4.1) 
(range: 1-16 years). 18 (30%) subjects were quadriplegic, 35 (57%) were paraplegic and 
8 (13%) subjects were fully independent; having neurogenic bladder with preserved 
upper and lower limb functions (Table 1). 
Figure 1 illustrates the proportion of male, female and all subjects requiring 
prophylaxis at the time of last follow-up.  
 
Figure 1. Subjects on PRx by Gender. Bar graph illustrates number of subjects on UTI 
prophylaxis by gender and by total number of subjects. +PRx = subjects using 
prophylaxis;  -PRX = Subjects not using prophylaxis; UTI = urinary tract infection 
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The initial date of PRx use was noted in 39 of 41 subjects and the results 
demonstrate that 28 (72%) were started on PRx within 2 years after initiation of CIC 
(Figure 2). The mean duration of follow-up for subjects on PRx as well as for those not 
using PRx are provided in Table 1. The date of initial catheter use was noted in 18 of the 
20 (90%) subjects not requiring PRx. 
 
Figure 2. Subjects on PRx by years after starting CIC. Bar graph illustrates number of 
subjects started on UTI prophylaxis based on the number of years after starting CIC. CIC 
= clean intermittent catheterization; PRx = prophylaxis; UTI = urinary tract infection. 
 
Table 2 lists the number and percentage of subjects on UTI PRx with the number 
of positive cultures, ≥ 10
3 
cfu/ml, available within the year prior to starting them on PRx. 
Culture results were not available for 11 (27%) of these subjects. Of the 20 subjects not 
placed on UTI PRx, 15 had no complaints of UTI symptoms in the final year of follow. 
The remaining 5 subjects were each noted to have had only one complaint of 
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symptomatic UTI. Three of these subjects had a positive culture, ≥ 10
3
cfu/ml, each. 
Culture results were not available for the other 2 subjects. 
 
Table 2. Culture Results for Subjects on UTI PRx 
Cx ≥ 10
3
 cfu n (%) 
≥3 17 (41) 
2 7 (17) 
1 6 (15) 
Cx = cultures; cfu = colony forming units; UTI = 
urinary tract infection; PRx = prophylaxis. 
 
b) Of the spinal cord injury patients identified in specific objective (a), 48 subjects met 
criteria for inclusion in the evaluation of renal tract ultrasonography as a long-term 
surveillance method. 
The mean age of these subjects was 44.8 years (range: 13-84 years) (Table 3). 
Included subjects had been followed for a mean duration of 6.8 years (±3.7) (range: 2-16 
years). 26 (54%) subjects were paraplegic, 16 (33%) subjects were quadriplegic and 6 
(13%) subjects had adequate function of all extremities. On average subjects were 
followed with ultrasonography for 5.2 years (±2.6) (range: 1-9 years) and the average 
time between the most recent urodynamic testing and the last ultrasound follow-up was 
4.8 years (±3.3).  
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Table 3. Patient Characteristics 
Age (y) 44.8 (range: 13-84) 
Sex (n)  
Male 40 (83) 
Female 8 (17) 
Injury level (n)  
Cervical 22 (46) 
Thoracic 16 (33) 
Lumbar 10 (21) 
Disability (n)  
Paraplegia 26 (54) 
Quadriplegia 16 (33) 
Independent 6 (13) 
Duration of follow-up (y) 6.8 (±3.7) 
Duration of U/S follow-up (y) 5.2 (±2.6) 
Data presented as mean SD, unless noted otherwise; 
data in parentheses are percentages. U/S = ultrasound. 
 
Table 4 shows the results of the most recent urodynamic testing in 45 (94%) subjects. 
Results of recent urodynamic testing were not available for three subjects. 
 
Table 4. Most recent urodynamic findings 
DO 36 (80) 
DA/DU 9 (20) 
Pseudo-DSD 1 (2) 
DSD 9 (20) 
Decreased bladder compliance 9 (20) 
Data presented as counts (n); data in parenthesis are 
percentages. DO = detrusor overactivity; DA = detrusor 
areflexia; DU = detrusor underactivity; DSD = detrusor 
sphincter dyssynergia. 
 
The results of initial and final ultrasonography exams are illustrated in Figure 3. At 
the time of initial retroperitoneal ultrasound, a small renal calculus was present in 1 (2%) 
subject, 6 (13%) subjects were noted to have cortical scarring and moderate to minimal 
hydronephrosis/caliectasis were found in 5 (10%) subjects. 2 of the 5 cases of upper tract 
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dilation that were present on initial ultrasound had completely resolved by the final 
follow-up exam. 
At the time of last follow-up, final ultrasonography demonstrated small renal/ureteral 
calculi in 5 (10%) subjects of which one case was stable compared to the initial exam. No 
new cases of renal cortical scarring/thinning were noted and 3 cases of scarring were 
stable compared to the initial, while the other 3 cases that were previously noted on initial 
ultrasound were not reported in the final ultrasound exams. 
 
Figure 3.Comparison of Initial vs Final Ultrasound Findings. Bar graph illustrates the 
changes in retroperitoneal ultrasound findings between the initial ultrasound and the 
final ultrasound at last follow-up. Hydroneph = hydronephrosis; U/S = ultrasound. 
 
Moderate to minimal hydronephrosis/caliectasis was present in 7 (15%) subjects at 
the time of the final surveillance. Of these, 3 cases were stable and 4 (8%) cases were 
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new compared to the initial assessment.  3 of the 4 new cases of mild hydronephrosis 
were secondary to obstruction by ureteral calculi in 2 cases and by an enlarged prostate in 
the third. The three subjects were treated with laser lithotripsy, extra-corporeal 
shockwave lithotripsy and finasteride respectively. No cases of severe hydronephrosis 
occurred. 
 
c)  For suprapubic cystostomy using the lowsley retractor method, 49 elective cases of 
primary suprapubic catheter placements were performed on 44 patients with 
neurogenic bladder using a curved lowsley retractor. 23 (52.3%) males and 
21(47.7%) females underwent the procedure (Table 5). 
Table 5. Patient characteristics 
Age (Yr) 44.7 (18.0) (range: 18-86) 
Sex (n)  
    Female 21 (47.7) 
    Male 23 (52.3) 
NGB Etiology (n)  
    Spinal cord injury 29 (65.9) 
    Multiple sclerosis 9 (20.5) 
    Cerebral palsy 1 (2.3) 
    Spina bifida 1 (2.3) 
    Spinocereballar ataxia 1 (2.3) 
    Amytropic lateral sclerosis 1 (2.3) 
    Parkinson’s disease 1 (2.3) 
    Anticholinergic side effect 1 (2.3) 
Data presented as mean  SD, unless noted otherwise; data in 
parentheses are percentages. NGB = neurogenic bladder 
 
 The etiology of neurogenic bladder was spinal cord injury in 29 (65.9%) subjects and 
multiple sclerosis in 9 (20.5%) subjects. The other 6 (13.6%) patients had neurogenic 
bladder from spina bifida, spinocereballar ataxia, cerebral palsy, amyotropic lateral 
sclerosis, parkinson’s disease and anticholinergic medication side effect. The mean age 
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for all subjects was 44.7 years (18.0) (range: 18-86 years). The mean age was similar 
for males and females, 41.5 years (17.2) and 47.7 years (18.5) respectively, P = 0.23. 
8 (16.3%) cases were successfully performed with local and monitored anesthesia 
care (Table 6). 
Table 6. Operative experience 
Anesthesia type (n)  
    General anesthesia 41 (83.7) 
    Local + MAC 8 (16.3) 
Operation time (min.) 20.2 (5.5) (range: 11-31) 
Blood loss minimal 
IV Fluids (mL Crystalloids ) 461.2 ( 222.0) 
Foley catheter size (Fr) range: 16-22 Fr 
Complications (n)  
    Hematuria 1 (2.0) 
Data presented as mean  SD, unless noted otherwise; data in parentheses are 
percentages. MAC = monitored anesthesia care 
 
 All other cases were performed under general anesthesia. The mean operation 
time documented in 19 (38.7%) cases was 20.2 min (5.5) (range: 11-31 min). Blood 
loss was reported as zero or minimal in all cases and records indicate a mean fluid 
administration of 461.2 mL crystalloids (222.0) in 31 (63.3%) cases. The median 
catheter size inserted was 20-Fr Foley catheter (range: 16-22 Fr). There were no cases of 
incorrect catheter placement and no intra-operative complications. One patient returned 
with significant hematuria a day following the procedure; Clavian Grade I. No other 
minor or major complications were noted. 
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DISCUSSION 
Urologic advances are credited for the reduced mortality observed in spinal cord 
injury patients in recent decades. The improved life expectancy now makes long-term 
complications of urinary tract management more pertinent therefore mandating the need 
for continued research in this arena. This research retrospectively reports our institutional 
outcomes in the long-term management of neurogenic bladder in patients with traumatic 
spinal cord injury. 
The first objective addressed the association of recurrent urinary tract infections 
with the long-term use of CIC in identified spinal cord injury patients followed by the 
same physician at the Yale Urology medical group. CIC is a common bladder 
catheterization method used in the years following spinal cord injury [50]. Some studies 
looking at its efficacy have observed an increased frequency of UTI raising the need for 
prophylactic antibiotics [50]. Oral antimicrobials, methenamine compounds and bladder 
instillations of providone iodine and chlorhexidine preparations are often used and have 
been shown to postpone bacteriuria for short periods in patients managed with CIC [51, 
52]. Daily use of low-dose systemic antimicrobials such as trimethoprim-
sulfamethoxazole has also been shown to be effective in reducing bacteriuria and 
symptomatic UTI in persons with acute SCI [53]. The routine use of methenamine 
products or systemic antimicrobials for prophylaxis in long-term intermittent 
catheterization is controversial and not recommended [22], however in carefully selected 
subjects with frequent recurrent symptomatic UTIs this may help improve quality of life.  
Our results demonstrated that 67% of our subjects were on UTI prophylaxis at the 
time of last follow-up (Figure 1). And that most of these patients were started on 
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prophylaxis within two years of initiating bladder management with CIC (Figure 2). UTI 
prophylaxis in this case was defined as the use of oral antimicrobials or methenamine 
combined with ascorbic acid. In an acidic environment methenamine forms formic acid 
which serves as a bladder antiseptic. Ascorbic acid is used to lower the urine pH 
sufficiently for generation of formic acid. Theoretically the combination is effective in 
reducing UTI without leading to antibiotic resistance. 
Our patients were placed on prophylaxis only after they complained of three or 
more episodes of symptomatic UTIs within a one year period and where available, urine 
culture results were used to confirm the need of PRx in those subjects using PRx. The 
diagnosis of UTI is usually based on the quantification of uropathogens in voided urine, 
with significant bacteriuria defined as the amount of uropathogens in urine which 
distinguishes true infection or colonization of the urinary tract from contamination [54]. 
The National Institute on Disability and Rehabilitation Research (NIDRR) defines UTI 
by the presence of significant bacteriuria with tissue invasion and resultant tissue 
response with signs and/or symptoms of UTI [55]. The criteria for significant bacteriuria 
in SCI patients are dependent on the method of bladder management being used. To be 
diagnosed with catheter associated UTI, patients managed with intermittent 
catheterization require ≥ 10
3
 cfu/ml in addition to UTI symptoms un-attributable to other 
sources [56]. This cut-off for positive cultures was used to confirm the need for PRx in 
the subjects included in this study. 
Urine culture results were found for 31 of 41 (76%) subjects placed on PRx 
however culture results were not available for those subjects that were started on PRx at 
initial follow-up after they have been referred to our institution for management of 
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frequent recurrent infections. In addition, culture results were not available for other 
subjects since patients are often treated outside the purviews of our office with cultures 
done by their primary care providers.  Of all subjects included in the study, 17 had at 
least three positive cultures within the year prior to starting UTI PRx confirming that at 
least 28% of our SCI patients were experiencing recurrent symptomatic UTI. These 
results suggest that symptomatic UTIs remain a frequent, recurrent complication of clean 
intermittent catheterization. 
Due to the small number of females included in our study we could not determine 
whether the difference in the percentage of male and female subjects requiring UTI PRx 
was statistically significant. The issue of sex as an independent risk factor for UTI in SCI 
patients remains unresolved. It is well known however that females have a higher 
incidence of UTI compared to males in otherwise healthy individuals with normal 
bladder function. Since females represent a minority of those with spinal cord injury only 
a few studies have compared complication outcomes in male and female SCI patients. 
Waites and colleagues did not find sex to be an independent risk factor for UTI in a 
prospective study of 61 SCI patients [57]. However a comparative study by Bennett and 
associates demonstrated a higher incidence of UTI in females, especially with bowel 
organisms [58, 59]. Another study of 302 SCI patients on CIC found a significantly 
higher rate of clinical UTI in women even though men and women had equal rates of 
bacteriuria [60]. 
 Most of our patients on UTI PRx required it within 2 years of initiating bladder 
management with CIC. However, the 20 patients not placed on UTI PRx had been 
followed for a mean of 7 years without the need for PRx. These results suggests that 
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patients who will be placed on PRx are started on it early in the course of management, 
while those not needing PRx could go on without PRx almost indefinitely. Future studies 
will be needed to address what factors influence why certain patients do not experience 
frequent recurrent UTI while undergoing long-term bladder management with CIC.  
The finding that 67% of our SCI patients are placed on PRx within 2 years of 
starting CIC is high and may not be generalizable to the average SCI population since 
patients are often referred to our institution for management because they have been 
experiencing frequent symptomatic infections.  Previous studies have reported that up to 
eighty to ninety percent of persons with acute SCI have bacteriuria within 2 to 3 weeks of 
starting intermittent catheterization [53]. Esclarin and colleagues found an incidence of 
2.75 episodes of bacteriuria/100 Person-days, with 0.41 episodes/100 person-days 
incidence for UTI in a retrospective study of adults with acute SCI [61]. Unlike previous 
reports, our study investigates the association of symptomatic UTI with long-term CIC in 
stable rather than acute SCI. Our results demonstrate that recurrent UTI remains a major 
complication of long-term bladder management with clean intermittent catheterization. 
An increased incidence of symptomatic UTI has been reported when CIC is performed at 
home by a caregiver rather than by the person with SCI [62]. However most of the factors 
contributing the increased risk of UTI in patients with CIC remain controversial and 
future studies are needed to fully define the risk factors. 
The second specific objective evaluated the efficacy of retroperitoneal 
ultrasonography as a long-term surveillance method in injured patients managed with 
CIC. All patients included in this study were managed with CIC and the results of their 
most recent video urodynamics revealed detrusor overactivity in 80%, detrusor sphincter 
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dyssynergia in 20% and decreased bladder compliance was also present in 20% of those 
included. The standard first line therapy in patients with neurogenic detrusor overactivity 
is intermittent catheterization along with oral anticholinergic treatment for detrusor 
relaxation [63] because upper tract dilation is caused by a poorly compliant bladder with 
high pressure whether or not vesicoureteral reflux is present [64]. Consequent 
hydroureteronephrosis in neurogenic bladder patients may cause renal deterioration, renal 
failure and death [65]. 
 Study subjects with detrusor overactivity who reported having incontinence or 
those with inadequate storage pressures were managed initially with oral anticholinergic 
medications to suppress the involuntary contractions, prevent urinary incontinence and 
protect the kidneys from high pressures. Urodynamic testing was repeated if patients 
presented with new symptoms including recurrent urinary tract infections, incontinence 
or increased frequency of catheterization and their management regimen was modified. 
Modifications to management strategies in study subjects included optimization of 
anticholinergic medication dose, addition of another anticholinergic such as imipramine 
or surgical intervention with augmentation cystoplasty. 
We retrospectively assessed our population of spinal cord injury patients with 
neurogenic bladder for the long-term results of a management regime based on annual 
ultrasonography. Urodynamics were repeated only after patients presented either with 
new symptoms or with abnormal findings on ultrasonography. Our series demonstrated 
that compared to initial ultrasonography, by the time of last follow-up there were 4 (8%) 
new cases of moderate or minimal hydronephrosis/caliectasis and 4 (8%) new cases of 
small renal/ureteral calculi. 3 of the 4 cases of upper tract dilation however was 
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secondary to distal obstruction from calculi and prostatic hyperplasia and no cases 
required modification of the bladder management regime. Furthermore, no cases of 
severe upper tract dilatation or large stone burden were observed in any of our patients. 
All cases of upper tract dilation noted on initial ultrasonography had either resolved or 
remained stable by the time of last follow-up after initial management was modified 
either by increasing the dosage of anticholinergics or after augmentation cystoplasty was 
performed.   
 Patients managed on an annual urodynamics based regime by Nossseir and 
colleagues had no cases of upper tract damage; their series included 51 patients managed 
with intermittent catheterization and anticholinergic pharmacotherapy [49]. Although a 
significant number of their patients, 10 (20%), suffered from recurrent urinary tract 
infections renal ultrasound demonstrated morphologically unaffected upper urinary tract 
in all patients. In our series however patients were followed with annual ultrasonography 
rather than urodynamics and 8% of our subjects developed mild cases of upper tract 
dilation. Most of these cases however were early manifestations of acute obstructive 
processes rather than late manifestations of inadequate bladder pressures. And it is 
unlikely that a more frequent bladder surveillance regime would have prevented the 
development of minimal caliectasis in these subjects. 
 We propose that after the initial treatment regime is implemented and a safe 
system is established, SCI patients managed with intermittent catheterization can be 
monitored regularly with retroperitoneal ultrasound alone; and further urodynamic testing 
reserved only for patients presenting with new symptoms, to prevent long-term upper 
tract damage. Our results demonstrate that bladder management based on annual 
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surveillance with ultrasound is sufficient to prevent upper tract damage in our population 
of SCI patients and future studies are needed to demonstrate the frequency of surveillance 
necessary to maintain upper tract function in the general SCI population managed with 
intermittent catheterization. 
Since neurogenic bladder (NGB) patients have been shown to be at increased risk 
of injury during suprapubic catheter placement, the third specific objective described our 
experience with a safe technique for suprapubic cystostomy (SPC) known as the lowsley 
retractor method. Suprapubic cystostomy is used to manage patients in acute urinary 
retention, those undergoing lower urinary tract operations as well as persons with 
neurogenic bladder.  Various percutaneous and minimally invasive methods for 
suprapubic cystostomy have been described but the open approach under general and 
spinal anesthesia is still accepted as the definite gold-standard [26]. NGB patients have 
been shown to have a higher risk of complication during SPC procedures [27]. Zeidman 
and colleagues in 1988 introduced a safe technique for suprapubic catheter placement 
using the lowsley retractor designed for perineal prostatectomy [66]. In reporting their 
institutional experience they noted no cases of incorrect catheter placement and had no 
major or minor complications. However their patient characteristics were not described in 
detail and their technique is sometimes avoided for concern of possible urethral injury 
and potential difficulty in obese patients [67, 29]. To our knowledge no other institutional 
experiences with this approach has been published since its initial introduction. This 
report describes our institutional experience with the lowsley retractor method for 
isolated primary suprapubic catheter placement in NGB patients. 
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In their initial description of the technique, Zeidman and associates did not detail 
patient characteristics or their operative experience. They reported the use of the 
procedure in 125 female and 25 male patients needing cystostomy either as an isolated 
procedure or as part of a more extensive surgery. They only report the exclusion of male 
patients suffering from a fixed pelvic floor after radiation therapy due to difficulty of the 
procedure in this group of patients. Their approach was successful in all patients with no 
major or minor complications.  In this report we describe our experience with the lowsley 
retractor method for SPC as an isolated procedure in NGB patients. Our operative 
experience regarding operative time, blood loss, and fluids administered are reported in 
detail to fully describe the safety and ease of utilizing this technique. 
Surgical Technique 
Similar to the technique previously described by Zeidman, the patient is placed in dorsal 
lithotomy position.  A curved lowsley retractor is advanced through the urethral meatus 
into the bladder and pointed to the anterior abdominal wall.  A small suprapubic incision 
is carried through the subcutaneous tissues and the abdominal wall using sharp dissection 
or electrocautery until the head of the lowsley retractor is met. The retractor is advanced 
through the incision and a 2-0 silk tie is used to tie a Foley catheter (of desired size) to 
the head of the lowsley retractor. The catheter is withdrawn into the bladder and out the 
urethral meatus using the retractor. The silk tie is cut releasing the end of the Foley 
catheter. The catheter is then pulled back through the meatus into the bladder. The 
balloon is inflated (10-15 cc), then a rigid cystoscope is introduced into the bladder 
confirming appropriate inflation of the catheter within the bladder. The bladder is 
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allowed to drain spontaneously via the catheter and the catheter is sutured to the skin 
using interrupted 2-0 nylon suture.  
 The procedure was fast and effective.  The operative time was recorded in 19 of 
49 cases with a mean of 20.2 minutes (range: 11 – 31 min). All patients had minimal 
blood loss and on average required about 500 mL of intravenous crystalloids during the 
operation. In the 8 cases where general anesthesia was not used, the patients tolerated the 
procedure well under local anesthesia with monitored anesthesia care. There were no 
cases of incorrect catheter placements and no intra-operative complications. Our only 
complication was in a female spinal cord injury patient who returned to the emergency 
department a day following catheter placement with significant hematuria and 
hypotension. This complication occurred after her suprapubic catheter was inadvertently 
tugged-on at an outpatient care facility. Her hematuria resolved with conservative 
management and her pressures normalized after intravenous administration of fluids and 
fresh frozen plasma. The lack of other major or minor complications using this technique 
is consistent with the outcomes reported by Zeidman in 1988. We did not have any cases 
of urethral injury and to our knowledge no cases of urethral injury using the lowsley 
retractor method have been published. This suggests that the theoretical risk of possible 
urethral injury may be easily avoidable. Also, attempts should be made in future reports 
to address outcomes in obese patients undergoing this method of SPC. 
 
CONCLUSION 
Although intermittent catheterization is widely viewed as the healthiest bladder 
management option, many patients managed with long-term CIC will frequently 
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experience recurrent symptomatic urinary tract infections. Our results highlight the 
continued need for improvements in bladder management methods to reduce rates of 
symptomatic infections in these patients. Future studies are needed to determine the 
benefit of UTI prophylaxis in these patients and to address what factors influence why 
certain patients managed with long-term CIC continue to experience frequent 
symptomatic infections when others do not. 
While the combination of CIC and oral anticholinergic therapy is a successful first 
line regimen in SCI patients with neurogenic bladder, these patients will often require a 
variety of treatment modifications and interventions in long-term follow-up to prevent 
upper tract deterioration [41]. This retrospective analysis of patients monitored with 
annual retroperitoneal ultrasound rather than regular urodynamics demonstrates that an 
ultrasound based surveillance regime is efficacious. Future studies are needed to 
determine the optimal surveillance interval with ultrasonography to prevent upper tract 
deterioration in spinal cord injury patients managed with clean intermittent 
catheterization. 
Due to improved pharmacotherapy with anticholinergics, SPC is emerging as an 
effective alternative for the long-term management of NGB patients [26]. Patients using 
this bladder management method report a high level of satisfaction as well as an 
improved quality of life [25]. Various percutaneous procedures have been demonstrated 
for suprapubic catheter placements, but patients with NGB have been demonstrated to 
have a higher risk of complications following the procedure [27]. This report describes 
our experience with SPC using the lowsley retractor method introduced by Zeidman et al. 
in 1988. Our findings demonstrate that the technique is easy and safe for performing 
   - 35 - 
  
primary cystostomy as an isolated ambulatory procedure in patients with neurogenic 
bladder. 
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